Literature DB >> 21212409

Increased efficacy of breast cancer chemotherapy in thrombocytopenic mice.

Mélanie Demers1, Benoit Ho-Tin-Noé, Daphne Schatzberg, Janie J Yang, Denisa D Wagner.   

Abstract

Platelets contribute to homeostasis of the tumor vasculature by helping prevent hemorrhage. Thus, we hypothesized that inducing thrombocytopenia would increase tumor vascular leakiness and facilitate the effective delivery of chemotherapeutic agents to tumors. In a mammary carcinoma murine model, platelet depletion induced bleeding specifically at the tumor site, favoring the accumulation of fluorescently labeled microspheres only in the tumor. Moreover, induction of thrombocytopenia in tumor-bearing mice before injection of paclitaxel increased its intratumoral accumulation and reduced growth of both slow- and fast-growing tumors, compared with mice with normal platelet counts that were treated only with paclitaxel. Histologic analysis confirmed the expectation of an increase in tumor apoptosis and a reduction in tumor proliferation in thrombocytopenic mice receiving chemotherapy. No increased toxicity was seen in other organs or blood cells. Taken together, our results indicate that low platelet count selectively induces leakiness of tumor vessels and favors the delivery of chemotherapy to tumor sites, enhancing its tumoricidal effects. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21212409      PMCID: PMC3078642          DOI: 10.1158/0008-5472.CAN-10-2038

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  31 in total

1.  Genes expressed in human tumor endothelium.

Authors:  B St Croix; C Rago; V Velculescu; G Traverso; K E Romans; E Montgomery; A Lal; G J Riggins; C Lengauer; B Vogelstein; K W Kinzler
Journal:  Science       Date:  2000-08-18       Impact factor: 47.728

Review 2.  Autologous platelets as a source of proteins for healing and tissue regeneration.

Authors:  Eduardo Anitua; Isabel Andia; Bruno Ardanza; Paquita Nurden; Alan T Nurden
Journal:  Thromb Haemost       Date:  2004-01       Impact factor: 5.249

Review 3.  Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer.

Authors:  Napoleone Ferrara; Kenneth J Hillan; Hans-Peter Gerber; William Novotny
Journal:  Nat Rev Drug Discov       Date:  2004-05       Impact factor: 84.694

4.  Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor.

Authors:  C J Aslakson; F R Miller
Journal:  Cancer Res       Date:  1992-03-15       Impact factor: 12.701

5.  Immunology of spontaneous mammary carcinomas in mice. V. Acquired tumor resistance and enhancement in strain A mice infected with mammary tumor virus.

Authors:  M A Attia; D W Weiss
Journal:  Cancer Res       Date:  1966-08       Impact factor: 12.701

Review 6.  What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia?

Authors:  Richard J Benjamin; Kenneth C Anderson
Journal:  Crit Rev Oncol Hematol       Date:  2002-05       Impact factor: 6.312

7.  Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3.

Authors:  J C Gutheil; T N Campbell; P R Pierce; J D Watkins; W D Huse; D J Bodkin; D A Cheresh
Journal:  Clin Cancer Res       Date:  2000-08       Impact factor: 12.531

8.  Angiogenesis, microvascular architecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice.

Authors:  M Leunig; F Yuan; M D Menger; Y Boucher; A E Goetz; K Messmer; R K Jain
Journal:  Cancer Res       Date:  1992-12-01       Impact factor: 12.701

9.  Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions.

Authors:  Judith A Coppinger; Gerard Cagney; Sinead Toomey; Thomas Kislinger; Orina Belton; James P McRedmond; Dolores J Cahill; Andrew Emili; Desmond J Fitzgerald; Patricia B Maguire
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

Review 10.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

View more
  25 in total

Review 1.  Platelets: a critical link between inflammation and microvascular dysfunction.

Authors:  Karen Y Stokes; D Neil Granger
Journal:  J Physiol       Date:  2011-12-19       Impact factor: 5.182

2.  Targeting platelet function to improve drug delivery.

Authors:  Mélanie Demers; Denisa D Wagner
Journal:  Oncoimmunology       Date:  2012-01-01       Impact factor: 8.110

Review 3.  The Platelet Lifeline to Cancer: Challenges and Opportunities.

Authors:  Monika Haemmerle; Rebecca L Stone; David G Menter; Vahid Afshar-Kharghan; Anil K Sood
Journal:  Cancer Cell       Date:  2018-04-12       Impact factor: 31.743

4.  GPVI inhibitor as antitumor gateway drug.

Authors:  Lawrence E Goldfinger
Journal:  Blood       Date:  2019-06-20       Impact factor: 22.113

5.  Hepatic thrombopoietin gene silencing reduces platelet count and breast cancer progression in transgenic MMTV-PyMT mice.

Authors:  Toshiaki Shirai; Alexey S Revenko; Justin Tibbitts; Anh T P Ngo; Annachiara Mitrugno; Laura D Healy; Jennifer Johnson; Erik I Tucker; Monica T Hinds; Lisa M Coussens; Owen J T McCarty; Brett P Monia; András Gruber
Journal:  Blood Adv       Date:  2019-10-22

Review 6.  Platelets at the interface of thrombosis, inflammation, and cancer.

Authors:  Aime T Franco; Adam Corken; Jerry Ware
Journal:  Blood       Date:  2015-06-24       Impact factor: 22.113

7.  Platelets promote mitochondrial uncoupling and resistance to apoptosis in leukemia cells: a novel paradigm for the bone marrow microenvironment.

Authors:  Juliana Velez; Leonardo José Enciso; Marta Suarez; Michael Fiegl; Adriana Grismaldo; Catalina López; Alfonso Barreto; Claudia Cardozo; Pilar Palacios; Ludis Morales; Jorge Eduardo Duque; Jorge Uriel Carmona; Marina Konopleva; Michael Andreeff; Ismael Samudio
Journal:  Cancer Microenviron       Date:  2014-08-12

8.  Chemotherapy Response Rates Among Patients With Endometrial Cancer Who Have Elevated Serum Platelets.

Authors:  Nora T Kizer; Hatem Hatem; Elizabeth K Nugent; Gongfu Zhou; Kathleen Moore; Paul Heller; David G Mutch; Premal H Thaker
Journal:  Int J Gynecol Cancer       Date:  2015-07       Impact factor: 3.437

9.  Cell-penetrable mouse forkhead box protein 3 alleviates experimental arthritis in mice by up-regulating regulatory T cells.

Authors:  Xia Liu; Baoju Ji; Mengyi Sun; Weijiang Wu; Lili Huang; Aihua Sun; Yangyong Zong; Sheng Xia; Liyun Shi; Hui Qian; Wenrong Xu; Qixiang Shao
Journal:  Clin Exp Immunol       Date:  2015-05-10       Impact factor: 4.330

10.  Anticoagulation inhibits tumor cell-mediated release of platelet angiogenic proteins and diminishes platelet angiogenic response.

Authors:  Elisabeth M Battinelli; Beth A Markens; Rajesh A Kulenthirarajan; Kellie R Machlus; Robert Flaumenhaft; Joseph E Italiano
Journal:  Blood       Date:  2013-09-24       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.